Who Paid My Doc
Outcomes Research
Research payments
$6,346,500
Through program year 2022, $6,346,500 in research payments was reported against Outcomes Research, across 170 payments, paid by Novartis Pharmaceuticals Corporation.
- Paid by
- Novartis Pharmaceuticals Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $127,120 | 10 |
| 2021 | Research | $17,151 | 5 |
| 2020 | Research | $354,256 | 55 |
| 2019 | Research | $5,847,973 | 100 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Surya Singh Boston, MA Named on 2 payments
- Brian Costello Rochester, MN Named on 2 payments
- John Hovanesian Laguna Hills, CA Named on 1 payment
- Vibeke Strand Portola Valley, CA Named on 1 payment
- Gregg Fonarow Los Angeles, CA Named on 1 payment
- Jeffrey Suh Los Angeles, CA Named on 1 payment
- Roger Goldberg Walnut Creek, CA Named on 1 payment
- Kristine Kuhn Aurora, CO Named on 1 payment
- Annette Okai Dallas, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.